Analysis
In-depth analysis of pharmaceutical markets, supply chains, technology and regulation
#regulatory ×
Analysis
Sep 13, 2026•1 min read
South Korea Bio‑Health Exports Hit $1.41 B in August, +22.3% YoY
Korea’s bio‑health industry posted its highest August export ever, $1.41 billion, a 22.3% increase from last year, while cumulative 2026 exports reached $12.11 billion.
1
Analysis
Sep 1, 2026•1 min read
Samjin Pharma to Normalize HydraSec Supply After MFDS Pediatric Indication Withdrawal
Following MFDS removal of pediatric use for diacetyl hexyl smectite, demand shifted to HydraSec, causing shortages; Samjin Pharma expects supply normalization this week.